Compare Avantis (AVNT) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avantis vs Enzyme — how do they compare? Avantis trades at Rp1,775 (market cap Rp644,7M, Rp1,4T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Avantis is far larger — about 4.8× Enzyme's market cap, and Avantis's supply is capped (338,9M / 1B AVNT (34%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Avantis for 22 Days and Enzyme for 29 Days on average.
| AVNT | MLN | |
|---|---|---|
Market Cap | Rp644,7M | Rp134,13M |
Volume (24h) | Rp1,4T | Rp104,56M |
Circulating Supply | 338,9M / 1B AVNT (34%) | 3,3M MLN |
Typical Hold Time | 22 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Avantis (AVNT) is trading at Rp1,957 with a market cap of Rp647.99M, showing bullish technical signals across moving averages and oscillators. The token is currently trading near its pivot point of Rp1,875 with strong support at Rp1,676 and resistance at Rp2,133. With 34% of the 1M max supply in circulation and an average hold time of 22 days, the token demonstrates moderate distribution and holding patterns.
Overall outlook remains cautiously optimistic with technical indicators supporting bullish momentum, though RSI levels above 80 suggest potential overbought conditions. Key opportunities include continued technical strength and network growth, while risks include high volatility and regulatory uncertainty typical of cryptocurrency assets.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Avantis
Avantis is the largest RWA perpetuals DEX in DeFi, built on Base. It enables users to trade crypto and real-world assets such as FX, commodities, indices, and equities. Supported by Pantera and Coinbase, Avantis combines institutional-grade products with the transparency and accessibility of DeFi, offering leverage up to 500x.
Read more on AVNT →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
